Quantcast

Latest Heart failure Stories

2014-05-05 08:28:17

SAN DIEGO, May 5, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the quarter ended March 31, 2014. During the period, the Company made progress across multiple clinical and corporate fronts, including the ex?U.S. expansion of EPIC, it's pivotal Phase 3 study of MST-188 in sickle cell disease, and pipeline expansion with the acquisition of AIR001, a clinical-stage program. Other highlights included initiating a Phase 2 study of...

2014-04-30 11:51:15

Found to be 'safe and well tolerated' in randomized clinical trial A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarction. This effect,say the investigators, was consistent across all study sub-groups, but was "particularly obvious in patients undergoing reperfusion within six hours of symptom onset". Eplerenone, a mineralocorticoid receptor...

2014-04-29 23:11:01

UVA technique tailors pacemaker-defibrillator installation for best outcomes. Charlottesville, VA (PRWEB) April 29, 2014 Important new research from the University of Virginia Health System explains why patients with heart failure do or do not respond to a very effective form of treatment, cardiac resynchronization therapy (CRT). The research successfully identified which patients would benefit and enables doctors to create an unprecedented map of a patient’s heart to guide the...

2014-04-29 20:23:32

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Cardiovascular Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/world_market_cardiovascular_diagnostics_1.htmlThis report provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include:-- Electrocardiography including ECG testing, stress testing, Holter...

2014-04-29 12:29:21

Randy Shepherd, Kept Alive for 10 Months by the SynCardia Total Artificial Heart Powered by the Freedom Portable Driver, Walked the April 26, 2014 Long-Distance Course Honoring Pat Tillman TUCSON, Ariz., April 29, 2014 /PRNewswire/ -- Randy Shepherd's 4.2-mile walk in Pat's Run April 26, 2014, in the Phoenix area was more than a test of his endurance. It was part of his training for the most crucial event of his life--a heart transplant....

2014-04-28 12:30:28

DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/b9jbpq/global) has announced the addition of the "Global Hypertension Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Hypertension, also referred as arterial hypertension or high BP, is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Lifestyle habits such as diet, exercising, and smoking...

2014-04-28 10:11:32

Large sections of the genome that were once referred to as “junk” DNA have been linked to human heart failure, according to research from Washington University School of Medicine in St. Louis. So-called junk DNA was long thought to have no important role in heredity or disease because it doesn’t code for proteins. But emerging research in recent years has revealed that many of these sections of the genome produce RNA molecules that, despite not being proteins, still have important...

2014-04-25 09:44:40

Fibroblasts, cells long thought to be boring and irrelevant, could offer an alternative to heart transplants for patients with heart disease. Researcher Dr Milena Furtado, and her team from the Australian Regenerative Medicine Institute (ARMI) at Monash University, found the heart cell fibroblast is a close relative to a cardiomyocyte, the cell responsible for a healthy beating heart. In research published today in Circulation Research, Dr Furtado has found that cardiac fibroblasts are...

2014-04-16 08:32:01

Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced the completion of a $20 million financing. M. H. Carnegie & Co. and Lumira Capital led the financing as part of an international syndicate of institutional investors from Australia, the U.S. and Canada. The financing follows the company's completion...

2014-04-14 12:31:23

Considerable Opportunity Exists for Therapies Offering Reductions in Mortality and Hospitalization Rates, According to Findings from Decision Resources Group BURLINGTON, Mass., April 14, 2014 /PRNewswire/ -- Decision Resources Group finds that Servier's ivabradine (procoralan) is set to become the clinical gold-standard in the treatment of chronic heart failure (CHF). Already available in Europe, where it has enjoyed moderate use in CHF and stable angina patients, ivabradine's sound clinical...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related